Neuren Pharmaceuticals Ltd

NEW
ASX:NEU (Australia)  
A$ 17.51 -0.030 (-0.17%) Jul 16
75.15
P/B:
6.55
Market Cap:
A$ 2.22B ($ 1.56B)
Enterprise V:
A$ 1.93B ($ 1.35B)
Volume:
346.07K
Avg Vol (2M):
506.84K
Trade In:
Volume:
346.07K
Avg Vol (2M):
506.84K

Neuren Pharmaceuticals Ltd (ASX:NEU) Dividend

Neuren Pharmaceuticals Ltd (ASX:NEU) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of 0.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:NEU Dividend

Does Neuren Pharmaceuticals Ltd (ASX:NEU) pay a dividend?

Neuren Pharmaceuticals Ltd (ASX:NEU) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Neuren Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Neuren Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of 0.6% over the past 3 years.

What are dividend-paying alternatives to Neuren Pharmaceuticals Ltd?

For dividend-paying alternatives in Neuren Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.